Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Oncology December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Oncology December 22,2023

Targeted cancer treatment: Innovative approach could prevent serious side effects

byMedical University of ViennaCredit: AI-generated imageTargeted, highly effective cancer treatments often produce debilitating side effects. This is the case with one commonly used therapy whic

Oncology December 22,2023

Targeted cancer treatment: Innovative approach could prevent serious side effects

byMedical University of ViennaCredit: AI-generated imageTargeted, highly effective cancer treatments often produce debilitating side effects. This is the case with one commonly used therapy whic

Oncology December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Oncology December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Oncology December 22,2023

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste

Oncology December 22,2023

New therapeutic strategy for chemotherapy resistance in ovarian cancer

byThe Wistar InstituteDr. Rugang Zhang. Credit: The Wistar InstituteA study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of ste

Oncology December 22,2023

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Oncology December 22,2023

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Oncology December 22,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Oncology December 22,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Oncology December 22,2023

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the

Oncology December 22,2023

'Cure or nothing' doesn't capture the realities of modern cancer research and treatment

by Paul Workman,Institute of Cancer ResearchAbiraterone was the first treatment shown to be effective in men with advanced prostate cancer. Credit: Institute of Cancer ResearchCancer was in the

Oncology December 22,2023

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Oncology December 22,2023

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Oncology December 22,2023

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in

Oncology December 22,2023

New model explains how our immune system sometimes helps cancer spread

by Katie Willis,University of AlbertaCredit: CC0 Public DomainMathematicians at the University of Alberta have developed a model that explains how the immune system interacts with cancer—and in

Oncology December 22,2023

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul

Oncology December 22,2023

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul

Oncology December 22,2023